These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2523284)

  • 1. Cataract prevention in diabetic Octodon degus with Pfizer's sorbinil.
    Datiles MB; Fukui H
    Curr Eye Res; 1989 Mar; 8(3):233-7. PubMed ID: 2523284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor.
    Beyer-Mears A; Cruz E
    Diabetes; 1985 Jan; 34(1):15-21. PubMed ID: 3917257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonosmotic diabetic cataracts.
    Malone JI; Lowitt S; Cook WR
    Pediatr Res; 1990 Mar; 27(3):293-6. PubMed ID: 2138728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of aldose reductase and its inhibition on sugar cataract formation.
    Kador PF; Akagi Y; Kinoshita JH
    Metabolism; 1986 Apr; 35(4 Suppl 1):15-9. PubMed ID: 3083204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raman spectroscopic study of the effect of aldose reductase inhibitor on experimental diabetic cataract.
    Nozawa H; Yaginuma T; Mizuno A
    Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):194-201. PubMed ID: 3133929
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of M79175, an aldose reductase inhibitor, on experimental sugar cataracts].
    Ono H; Nozawa Y; Hayano S
    Nippon Ganka Gakkai Zasshi; 1982; 86(9):1343-50. PubMed ID: 6818854
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of aldose reductase inhibitor on experimental diabetic cataract monitored by laser Raman spectroscopy.
    Mizuno A; Nozawa H; Yaginuma T; Matsuzaki H; Ozaki Y; Iriyama K
    Exp Eye Res; 1987 Jul; 45(1):185-6. PubMed ID: 3115805
    [No Abstract]   [Full Text] [Related]  

  • 8. Aldose reductase inhibitors and prevention of galactose cataracts in rats.
    Unakar N; Tsui J; Johnson M
    Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1623-32. PubMed ID: 2545646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galactose cataract prevention with sorbinil, an aldose reductase inhibitor: a light microscopic study.
    Datiles M; Fukui H; Kuwabara T; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1982 Feb; 22(2):174-9. PubMed ID: 6799419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic cataracts in animal models: prevention and reversibility with aldose reductase inhibitors.
    Kador PF; Akagi Y; Kinoshita JH
    Diabet Med; 1985 May; 2(3):194-6. PubMed ID: 2952419
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevention of rat galactose cataract with topical aldose reductase inhibitor, E-1008].
    Tasaka H; Akagi Y; Yoshikawa T; Ikebe H; Takahashi Y; Chamoto K; Miyamoto Y; Terubayashi H
    Nippon Ganka Gakkai Zasshi; 1987 Feb; 91(2):246-53. PubMed ID: 3111200
    [No Abstract]   [Full Text] [Related]  

  • 12. Medical therapy in the prevention of cataract.
    Brown NA; Bron AJ
    Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 7)():748-54. PubMed ID: 3938085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study of the limitations of ARI treatment of streptozotocin-induced diabetic cataracts].
    Kojima M; Sasaki K
    Nippon Ganka Gakkai Zasshi; 1986 Dec; 90(12):1669-73. PubMed ID: 2950739
    [No Abstract]   [Full Text] [Related]  

  • 14. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
    Jacobson M; Sharma YR; Cotlier E; Hollander JD
    Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sorbinil protection of lens protein components and cell hydration during diabetic cataract formation.
    Beyer-Mears A; Cruz E; Nicolas-Alexandre J; Varagiannis E
    Pharmacology; 1982; 24(3):193-200. PubMed ID: 6803262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of stage-I sugar cataract by Sorbinil, an aldose reductase inhibitor.
    Beyer-Mears A; Cruz E; Varagiannis E
    Pharmacology; 1985; 31(2):88-96. PubMed ID: 3927328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the aldose reductase inhibitor sorbinil on the isolated cultured rat lens.
    Yeh LA; Rafford CE; Beyer TA; Hutson NJ
    Metabolism; 1986 Apr; 35(4 Suppl 1):4-9. PubMed ID: 3083208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The intraocular penetration of aldose reductase inhibitor in rat eyes].
    Kojima M; Sasaki K
    Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):57-62. PubMed ID: 3133930
    [No Abstract]   [Full Text] [Related]  

  • 19. Aldose reductase in diabetic cataracts.
    Kinoshita JH; Kador P; Catiles M
    JAMA; 1981 Jul; 246(3):257-61. PubMed ID: 6787220
    [No Abstract]   [Full Text] [Related]  

  • 20. Lens metabolism and cellular effects of aldose reductase.
    McLean P; Gonzalez AM; Sochor M; Hothersall JS
    Diabet Med; 1985 May; 2(3):189-93. PubMed ID: 2952418
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.